By
Adrianne Appel2024-04-26T18:49:00
Mobile health applications and similar technologies must notify customers following a data breach or risk violating the Federal Trade Commission’s (FTC) health breach notification rule (HBNR), part of a broad update approved by the agency.
Many providers of direct health services, such as hospitals and doctors, are required to protect personal information under the Health Insurance Portability and Accountability Act (HIPAA). The HBNR pertains to health entities not beholden to HIPAA, such as certain vendors of health records, and requires them to notify individuals about data incidents.
The FTC has applied the HBNR to mobile health applications, as its recent enforcement actions against GoodRx and Easy Healthcare show.
2024-06-12T02:05:00Z By Jeff Dale
The Department of Justice and Federal Trade Commission proposed telehealth company Cerebral pay a total of $7 million for its alleged sharing of patient data and deceptive business practices in violation of the FTC Act.
2024-04-30T20:18:00Z By Adrianne Appel
UnitedHealth Group’s response to a major cyberattack in February that wreaked havoc with medical payments nationwide has been “inadequate” and must be improved immediately, a group of 22 state attorneys general told the company.
2024-04-29T18:50:00Z By Jeff Dale
Kitchen and home retail company Williams-Sonoma agreed to pay nearly $3.2 million for failing to comply with a 2020 administrative order by the Federal Trade Commission prohibiting its marketing of imported goods as made in the United States.
2025-12-10T15:30:00Z By Neil Hodge
For the past decade, Europe has led in creating strong but flexible rules for data use and safe AI development. The EU’s new plans to simplify key data privacy and AI governance measures have received a mixed response.
2025-12-05T19:25:00Z By Oscar Gonzalez
The U.S. Securities and Exchange Commission’s (SEC) Division of Examinations released its 2026 examination priorities, which give companies a roadmap of areas of heightened risk and regulatory focus for next year.
2025-12-04T22:15:00Z By Ruth Prickett
Regulation is a matter of life and death in the pharmaceutical industry. Rules to combat practices that can kill have been in force for decades, but tech developments are rapidly creating new risks and focusing lawmakers’ attention on areas where some compliance teams may lack experience.
Site powered by Webvision Cloud